EUVIMEDEUVIMED entdecken
Leitlinie

Treatment of Nontuberculous Mycobacterial (NTM) Pulmonary Infection in the US Bronchiectasis and NTM Registry: Treatment Patterns, Adverse Events, and Adherence to American Thoracic Society/Infectious Disease Society of America Treatment Guidelines

Jennifer H Ku iD, Emily Henkle, Timothy R Aksamit, Alan Barker, Amanda E Brunton, Kevin L Winthrop, Bronchiectasis and NTM Research Registry investigators

Clinical Infectious Diseases · 13.01.2023 · 76 (2) · 338-341

DOI: 10.1093/cid/ciac788 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Clinical Infectious Diseases, online erschienen am 22.09.2022. Verfasst von Jennifer H Ku und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA. Hauptthemen laut MEDLINE: Mycobacterium Infections, Nontuberculous, Bronchiectasis, Communicable Diseases, Opportunistic Infections. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 12 Literaturangaben. Gefördert von: COPD Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Among 1038 participants with pulmonary Mycobacterium avium complex and 120 with Mycobacterium abscessus enrolled in the US Bronchiectasis and NTM Research Registry, less than half received antibiotic therapy in the 24 months before registry enrollment, of which less than half were guideline based. Adverse effects occurred in 21% of therapy recipients, of whom 33% discontinued therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mycobacterium Infections, NontuberculousBronchiectasisCommunicable DiseasesOpportunistic InfectionsLung DiseasesHumansMycobacterium avium ComplexLungNontuberculous Mycobacteria

Stichwörter der Autor:innen

Mycobacterium abscessusMycobacterium avium complexadverse effectsantibiotic treatmentnontuberculous mycobacterial infection

Autor:innen und Institutionen

  • Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA.
  • Oregon Health & Science University-Portland State University School of Public Health, Portland, Oregon, USA.
  • Department of Pulmonary Disease and Critical Care Medicine, Mayo Clinic, Rochester, Minnesota, USA.
  • Department of Pulmonary and Critical Care Medicine, Oregon Health & Science University, Portland, Oregon, USA.

ORCID-Profile: Jennifer H Ku

Förderung

  • COPD Foundation

Zitieren

APA

Ku, J. H., Henkle, E., Aksamit, T. R., Barker, A., Brunton, A. E., Winthrop, K. L., & Bronchiectasis and NTM Research Registry investigators (2023). Treatment of Nontuberculous Mycobacterial (NTM) Pulmonary Infection in the US Bronchiectasis and NTM Registry: Treatment Patterns, Adverse Events, and Adherence to American Thoracic Society/Infectious Disease Society of America Treatment Guidelines. Clinical Infectious Diseases, 76(2), 338-341. https://doi.org/10.1093/cid/ciac788

Vancouver

Ku JH, Henkle E, Aksamit TR, Barker A, Brunton AE, Winthrop KL, et al. Treatment of Nontuberculous Mycobacterial (NTM) Pulmonary Infection in the US Bronchiectasis and NTM Registry: Treatment Patterns, Adverse Events, and Adherence to American Thoracic Society/Infectious Disease Society of America Treatment Guidelines. Clinical Infectious Diseases. 2023;76(2):338-341. doi:10.1093/cid/ciac788

BibTeX
@article{Ku2023,
  author = {Ku, Jennifer H and Henkle, Emily and Aksamit, Timothy R and Barker, Alan and Brunton, Amanda E and Winthrop, Kevin L and Bronchiectasis and NTM Research Registry investigators, Bronchiectasis and NTM Research Registry investigators},
  title = {Treatment of Nontuberculous Mycobacterial (NTM) Pulmonary Infection in the US Bronchiectasis and NTM Registry: Treatment Patterns, Adverse Events, and Adherence to American Thoracic Society/Infectious Disease Society of America Treatment Guidelines},
  journal = {Clinical Infectious Diseases},
  year = {2023},
  volume = {76},
  number = {2},
  pages = {338--341},
  doi = {10.1093/cid/ciac788}
}
Kostenlos starten →